Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 19 citing articles:

Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 79
A Hybrid Nanoadjuvant Simultaneously Depresses PD‐L1/TGF‐β1 and Activates cGAS‐STING Pathway to Overcome Radio‐Immunotherapy Resistance
Yi Lei, Xin Jiang, Zaigang Zhou, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 26
In Vivo Applications of Dendrimers: A Step toward the Future of Nanoparticle-Mediated Therapeutics
Krzysztof Sztandera, J L Rodríguez-García, Valentı́n Ceña
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 439-439
Open Access | Times Cited: 12
Stimuli-Responsive Dendrimers as Nanoscale Vectors in Drug and Gene Delivery Systems: A Review Study
Niloufar Torabi Fard, Homayon Ahmad Panahi, Elham Moniri, et al.
Journal of Polymers and the Environment (2024) Vol. 32, Iss. 10, pp. 4959-4985
Closed Access | Times Cited: 9
Charting new frontiers: Co-inhibitory immune checkpoint proteins in therapeutics, biomarkers, and drug delivery systems in cancer care
Yao Xiao, Zi‐Zhan Li, Nian‐Nian Zhong, et al.
Translational Oncology (2023) Vol. 38, pp. 101794-101794
Open Access | Times Cited: 16
A Multistage‐Responsive Antibody‐Delivery Strategy to Improve Immunotherapy for NSCLC Brain Metastasis by Ultrasensitive Releasing and Tumor‐Anchoring
Shuaijun Li, Caiting Meng, Qian Hao, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 17
Closed Access | Times Cited: 7
Dual-pathway glycolysis inhibition for boosting bioenergetic therapy synergistic with chemodynamic/photothermal therapy
Pengxin Song, Renlu Han, Yun Gao, et al.
Chemical Engineering Journal (2024) Vol. 483, pp. 149248-149248
Closed Access | Times Cited: 7
Advancements in pH-responsive nanocarriers: enhancing drug delivery for tumor therapy
Zhouyun Chen, Xiaoxiao Wang, Na Zhao, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 11, pp. 1623-1642
Closed Access | Times Cited: 13
Nanoparticle-based drug delivery systems: opportunities and challenges in the treatment of esophageal squamous cell carcinoma (ESCC)
Linjia Peng, Zixuan Gao, Yan‐Feng Liang, et al.
Nanoscale (2025)
Open Access
Applications of Matrix Metalloproteinase-9-Related Nanomedicines in Tumors and Vascular Diseases
Xuying Li, Zhuping Xu
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 479-479
Open Access
Targeting tumour surface collage with hydrogel probe: a new strategy to enhance intraoperative imaging sensitivity and stability of bladder cancer
Pengyu Guo, Qi Ao, Wenting Shang, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 13, pp. 4165-4176
Closed Access | Times Cited: 2
Nanoscale synthetic biology with innovative medicinal applications
Jingsen Ji, Li Li, Weisheng Guo, et al.
Fundamental Research (2024)
Open Access | Times Cited: 2
Personalized nanovaccines for treating solid cancer metastases
Feng Tang, Jia Hu, Jirui Wen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Nano‐ and Micro‐Platforms in Therapeutic Proteins Delivery for Cancer Therapy: Materials and Strategies
Huijie Han, Hélder A. Santos
Advanced Materials (2024)
Open Access | Times Cited: 1
Intrinsic PD‐L1 Degradation Induced by a Novel Self‐Assembling Hexapeptide for Enhanced Cancer Immunotherapy
Hongxia Zhang, Ming Ji, Yamei Wang, et al.
Advanced Science (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 1
The clinicopathological significance and prognostic value of PD‐L1 in oral squamous cell carcinoma
Yizhan Li, Wenhao Ren, Shaoming Li, et al.
Oral Diseases (2024)
Closed Access
Nanomedicine-Based Cancer Immunotherapy
Syed Hammad Ali, Mohammad Azhar Aziz
Interdisciplinary cancer research (2024)
Closed Access
Recent Advancements of Nanomedicine in Breast Cancer Surgery
Xiangyue Meng, Xin Wang, Zhihao Zhang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 14143-14169
Open Access
Biomembrane-grafted dendrimer-polymeric conjugates for targeting p53—a pioneer innovation in cancer nanomedicine
Dilpreet Singh
Journal of Nanoparticle Research (2023) Vol. 25, Iss. 12
Closed Access | Times Cited: 1
Page 1

Scroll to top